Journal scan

Further evidence that taking statins can reduce risk of blood clots

Further evidence has come to light suggesting statins could significantly reduce the occurrence of blood clots in certain parts of the body.
Statins_tile_iStock.jpg

Further evidence has come to light which seems to suggest statins could significantly reduce the occurrence of blood clots in certain parts of the body.

Researchers from the University of Leicester and University of Bristol analysed several previous studies carried out on the cholesterol-lowering pill and found it could potentially lower the recurring risk of venous thromboembolism (VTE).

Meta-analysis of eight eligible studies involving a total of 103,576 participants identified 13,168 incidents of recurrent VTE.

New guidelines

Allowing for a 95% confidence interval the team found the relative risk for developing recurrent VTE between statin users and non-users was 0.73.

7

million people in the UK are believed to be on statins, at an estimated annual cost of 285 million.

Source: NHS Choices, 2014

...

Further evidence has come to light which seems to suggest statins could significantly reduce the occurrence of blood clots in certain parts of the body.


Statins could reduce the risk of venous thromboembolism by 15-25%. Picture: iStock

Researchers from the University of Leicester and University of Bristol analysed several previous studies carried out on the cholesterol-lowering pill and found it could potentially lower the recurring risk of venous thromboembolism (VTE).

Meta-analysis of eight eligible studies involving a total of 103,576 participants identified 13,168 incidents of recurrent VTE.

New guidelines 

Allowing for a 95% confidence interval the team found the relative risk for developing recurrent VTE between statin users and non-users was 0.73.

7

million people in the UK are believed to be on statins, at an estimated annual cost of £285 million.

Source: NHS Choices, 2014

It supported earlier work by the same researchers that suggested statins reduced the risk by 15-25%.

Lead researcher Setor Kunutsor said: 'Although our research has not identified a cause of VTE, they do underscore a potential role of statin therapy when dealing with the condition.'

It is hoped the discovery could potentially lead to new guidelines and an expansion of the use of treatment, which is already established in cardiovascular disease prevention.


Setor K. Kunutsor et al (2017), Statins and secondary prevention of venous thromboembolism: pooled analysis of published observational cohort studies, European Heart Journal. Doi: https://doi.org/10.1093/eurheartj/ehx107

 

Want to read more?

Subscribe for unlimited access

Enjoy 1 month's access for £1 and get:

  • Full access to nursing standard.com and the Nursing Standard app
  • Monthly digital edition
  • RCNi Portfolio and interactive CPD quizzes
  • RCNi Learning with 200+ evidence-based modules
  • 10 articles a month from any other RCNi journal

This article is not available as part of an institutional subscription. Why is this?

Jobs